Lomond Therapeutics Holdings, Inc. — Form D/A

Lomond Therapeutics Holdings, Inc. of DOVER, DE, a company, filed a Form D amendment with the SEC on 2025-02-11. The offering totals $63.9M, of which $53.9M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2025-02-11
Form: D/A
Accession: 0001213900-25-011898
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $63.9M
Amount sold: $53.9M
Remaining: $10.0M
Investors: 28
Date of first sale: 2024-11-01
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-529644

Issuer

Name: Lomond Therapeutics Holdings, Inc.
CIK: 0001900520
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 8 THE GREEN, SUITE 8490, DOVER, DE, 19901
Phone: 212-739-6400

Officers, directors & promoters (8)

Name	Role	Location
Iain Dukes	Director	Cambridge, MA
CARL GORDON	Director	SAN DIEGO, CA
Eddie Rodriguez	Director	Dover, DE
Nikolay Savchuk	Director	Dover, DE
Iain Dukes	Executive Officer	Cambridge, MA
Nikolay Savchuk	Executive Officer	Dover, DE
Carl Wang Gordon	Director	Dover, DE
Eddie Wang Rodriguez	Director	Dover, DE

Other filings by this issuer (1)

Filed	Form	Offering	Sold
2024-11-18	D	$43.9M	$43.9M

More